With
Quantitative User-Friendly Instant Clinical Kit
QUICKDx is a portable, rapid diagnostic system designed to detect specific disease biomarkers (antibodies, antigens, or small molecules) in under five minutes. The system consists of two core components:
At QUICKDx, we’re on a mission to make fast, reliable diagnostics available wherever they’re needed most. By bringing lab-quality testing for serious conditions like heparin-induced thrombocytopenia (HIT) to the point of care, we help doctors, first responders, and clinics make quicker, more accurate decisions. Our goal is to bridge the gap between centralized labs and everyday clinical settings, ensuring patients receive the right treatment without delay.
QUICKDx uses a microchip-based biosensor that detects molecular binding events by measuring changes in electrical properties. When a target molecule binds on the sensor surface, the electrical properties of the surface shift in a measurable way. These changes are rapidly analyzed by the onboard reader and translated into a digital output.
The value of the technology in QUICKDx lies in the platform’s ability to deliver:
Unlike lateral flow tests or ELISA, QUICKDx offers real-time immune monitoring and the flexibility to develop new tests rapidly using the same hardware platform.
Biotechnology entrepreneur with a background in physics, neuroscience, and business, focused on translating complex science into fast, practical diagnostic solutions.
Quantum technology expert with deep experience in molecular modeling and simulation, bringing technical precision to diagnostic platform design
Nanomaterials expert and innovation strategist skilled in productizing advanced technologies for national security and healthcare applications.